Rapact (Everolimus) Tablet is a prescription medication used to prevent organ rejection in kidney and liver transplant recipients and to treat certain types of cancer, including advanced renal cell carcinoma and neuroendocrine tumors. It functions as an immunosuppressant and a targeted therapy by inhibiting the mTOR pathway to control cell growth and proliferation. For more detailed medical information, you can visit Mayo Clinic, Drugs.com, FDA, WebMD, PubMed, Healthline, or WHO.

Key Benefits & Uses:

• Prevents organ rejection in kidney and liver transplants (FDA).

• Treats advanced renal cell carcinoma and neuroendocrine tumors (Drugs.com).

• Manages subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (PubMed).

• Reduces tumor growth by inhibiting the mTOR pathway (Mayo Clinic).

How to Use:

• Swallow Rapact tablets whole with a glass of water; do not crush or chew.

• Take with or without food consistently in the same manner each time.

• Follow your healthcare provider’s instructions regarding dosage and timing.

• Regular blood tests are necessary to monitor kidney function and drug levels (WebMD).

Important Safety Information:
Rapact may increase the risk of infections due to immunosuppression (Healthline). It may also cause high cholesterol, delayed wound healing, or lung/respiratory issues. Pregnant or breastfeeding women should consult their doctor before use (WHO). Always report any unusual symptoms to your healthcare provider.

Common Side Effects:

• Mouth ulcers

• Fatigue

• Rash

• Nausea and diarrhea

• Swelling in hands, feet, or legs (Mayo Clinic)

Why Choose Rapact:
Rapact offers proven efficacy in preventing organ rejection while also providing targeted cancer treatment benefits. With proper medical supervision, it can significantly improve patient outcomes and quality of life (FDA, Drugs.com).